Diversified Investment Strategies’s PetMed Express PETS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-6,155
Closed -$219K 42
2020
Q2
$219K Buy
+6,155
New +$214K 0.23% 33
2017
Q3
Sell
-86,025
Closed -$3.49M 45
2017
Q2
$3.49M Sell
86,025
-600
-0.7% -$18.6K 3.36% 8
2017
Q1
$1.75M Hold
86,625
1.73% 19
2016
Q4
$2M Sell
86,625
-400
-0.5% -$8.57K 2.09% 14
2016
Q3
$1.76M Hold
87,025
1.74% 15
2016
Q2
$1.63M Hold
87,025
1.64% 15
2016
Q1
$1.56M Buy
87,025
+68,000
+357% +$1.16M 1.64% 17
2015
Q4
$326K Hold
19,025
0.37% 41
2015
Q3
$306K Hold
19,025
0.37% 50
2015
Q2
$329K Hold
19,025
0.34% 50
2015
Q1
$314K Sell
19,025
-2,825
-13% -$43.8K 0.31% 52
2014
Q4
$314K Hold
21,850
0.28% 50
2014
Q3
$297K Hold
21,850
0.25% 53
2014
Q2
$295K Hold
21,850
0.22% 53
2014
Q1
$293K Hold
21,850
0.24% 55
2013
Q4
$363K Sell
21,850
-12,039
-36% -$188K 0.29% 54
2013
Q3
$552K Hold
33,889
0.45% 51
2013
Q2
$427K Buy
+33,889
New +$442K 0.36% 60

Other funds holding PETS

Diversified Investment Strategies's PETS Position: Q3 2020 in Review

Diversified Investment Strategies sold out of PetMed Express (PETS) in Q3 2020, closing a stake of 6,155 shares — an estimated $219K sold.

Diversified Investment Strategies first reported a position in PETS in Q2 2013 and held it in 18 quarters. The position peaked at $3.49M in Q2 2017. 201 funds tracked by Wall St. Rank hold PETS as of Q3 2020.

  • Diversified Investment Strategies reported no remaining PetMed Express position as of Q3 2020 after selling out during the quarter.
  • Diversified Investment Strategies sold 6,155 PetMed Express shares in Q3 2020, an estimated $219K.
  • Diversified Investment Strategies first reported a position in PetMed Express in Q2 2013 and held it in 18 quarters.
  • Diversified Investment Strategies's PetMed Express position peaked at $3.49M in Q2 2017.
  • 201 funds tracked by Wall St. Rank held PetMed Express as of Q3 2020.

Based on Diversified Investment Strategies's 13F filing for Q3 2020, filed 20 Oct 2020.